We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $389M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
+2.89%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
AUM
$257M
AUM Growth
+$289K
Cap. Flow
-$2.54M
Cap. Flow %
-0.99%
Top 10 Hldgs %
45.39%
Holding
73
New
4
Increased
11
Reduced
37
Closed
4

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$5.99M
2
MP icon
MP Materials
MP
+$3.99M
3
ABNB icon
Airbnb
ABNB
+$3.42M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$233K
5
JPM icon
JPMorgan Chase
JPM
+$190K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$9.61M
2
KHC icon
Kraft Heinz
KHC
+$880K
3
GLD icon
SPDR Gold Trust
GLD
+$838K
4
GILD icon
Gilead Sciences
GILD
+$503K
5
BG icon
Bunge Global
BG
+$436K

Sector Composition

Rank Sector Weight
1 Consumer Staples 15.77%
2 Communication Services 15.17%
3 Healthcare 14.75%
4 Materials 11.45%
5 Technology 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
1
SPDR Gold Trust
GLD
$131B
$25.5M 9.9%
142,936
-4,559
-3% -$838K
ALB icon
2
Albemarle
ALB
$13.9B
$12.9M 5%
57,588
+619
+1% +$127K
NFLX icon
3
Netflix
NFLX
$299B
$12.3M 4.8%
280,270
-7,780
-3% -$287K
META icon
4
Meta Platforms (Facebook)
META
$1.42T
$11.3M 4.39%
39,412
-1,755
-4% -$433K
BG icon
5
Bunge Global
BG
$20.4B
$11M 4.29%
116,948
-4,695
-4% -$436K
KHC icon
6
Kraft Heinz
KHC
$30.7B
$9.34M 3.63%
262,990
-22,870
-8% -$880K
GILD icon
7
Gilead Sciences
GILD
$162B
$8.89M 3.45%
115,340
-6,305
-5% -$503K
FDX icon
8
FedEx
FDX
$72.7B
$8.68M 3.37%
34,819
-1,835
-5% -$420K
SLB icon
9
SLB Ltd
SLB
$73.6B
$8.51M 3.3%
171,438
-2,077
-1% -$99K
IONS icon
10
Ionis Pharmaceuticals
IONS
$8.6B
$8.41M 3.27%
204,947
-5,751
-3% -$221K
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.36T
$7.85M 3.05%
65,560
-2,170
-3% -$250K
ABNB icon
12
Airbnb
ABNB
$89.9B
$7.75M 3.01%
60,472
+29,200
+93% +$3.42M
MDT icon
13
Medtronic
MDT
$109B
$7.38M 2.87%
83,690
+69,610
+494% +$5.99M
SYY icon
14
Sysco
SYY
$40.8B
$6.94M 2.7%
93,597
-3,515
-4% -$260K
INTC icon
15
Intel
INTC
$455B
$6.59M 2.56%
197,155
-1,854
-0.9% -$58.2K
NTR icon
16
Nutrien
NTR
$33.2B
$5.59M 2.17%
93,798
-2,646
-3% -$168K
WFC icon
17
Wells Fargo
WFC
$261B
$5.47M 2.12%
128,128
-680
-0.5% -$27.4K
ADBE icon
18
Adobe
ADBE
$99.5B
$5.37M 2.08%
10,977
-215
-2% -$86.6K
KO icon
19
Coca-Cola
KO
$377B
$5.22M 2.03%
86,041
-2,978
-3% -$185K
T icon
20
AT&T
T
$159B
$4.98M 1.94%
312,449
-5,810
-2% -$99K
AAPL icon
21
Apple
AAPL
$4.54T
$4.8M 1.86%
24,729
+85
+0.3% +$14.8K
MOS icon
22
The Mosaic Company
MOS
$7.03B
$4.43M 1.72%
126,664
-2,682
-2% -$104K
TRGP icon
23
Targa Resources
TRGP
$58B
$4.38M 1.7%
57,509
-975
-2% -$70.7K
CLX icon
24
Clorox
CLX
$11.6B
$4.1M 1.59%
25,767
+470
+2% +$75.8K
MP icon
25
MP Materials
MP
$7.36B
$3.99M 1.55%
+174,200
New +$3.99M

Similar funds

Sicart Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Sicart Associates held 73 positions worth $257M, up 0.11% from $257M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Sicart Associates's Q2 2023 filing shows 4 new, 11 increased, 37 reduced and 4 closed positions. Its largest new stake was MP Materials: 174,200 shares worth $3.99M. The largest sale was Merck, an estimated $9.61M.

By sector, the portfolio is most concentrated in Consumer Staples at 16% of assets, down from 17% a quarter earlier, followed by Communication Services and Healthcare.

  • Sicart Associates's largest Q2 2023 buy was MP Materials: 174,200 shares worth $3.99M.
  • Sicart Associates added most to Medtronic in Q2 2023, an estimated $5.99M increase.
  • Sicart Associates's biggest Q2 2023 reduction was Kraft Heinz, cutting an estimated $880K.
  • Sicart Associates fully exited Merck in Q2 2023, selling an estimated $9.61M.
  • Sicart Associates's ten largest holdings make up 45% of its $257M portfolio in Q2 2023.
  • Sicart Associates opened 4 new positions and closed 4 in Q2 2023.
  • Sicart Associates's portfolio value rose 0.11% quarter-over-quarter to $257M.

Based on Sicart Associates's 13F filing for Q2 2023, filed 28 Jul 2023.